As of 2025-08-29, the Intrinsic Value of CinCor Pharma Inc (CINC) is -10.06 USD. This CINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 29.06 USD, the upside of CinCor Pharma Inc is -134.63%.
Based on its market price of 29.06 USD and our intrinsic valuation, CinCor Pharma Inc (CINC) is overvalued by 134.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.06 - -10.06 | -10.06 | -134.63% |
| P/E | (38.45) - (39.17) | (39.05) | -234.4% |
| DDM - Stable | (23.20) - (92.26) | (57.73) | -298.7% |
| DDM - Multi | (7.54) - (23.19) | (11.36) | -139.1% |
| Market Cap (mil) | 1,271.79 |
| Beta | 1.02 |
| Outstanding shares (mil) | 43.76 |
| Enterprise Value (mil) | 979.23 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.02% |
| Cost of Debt | 5.00% |
| WACC | 5.84% |